Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Eldor

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Diabetes Care|August 27, 2016
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 DiabetesGiuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, et al.
Diabetes/Metabolism Research and Reviews|April 12, 2019
Exenatide modulates visual cortex responsesPaola Binda, Roy Eldor, Claudia Huerta, et al.
Cardiovascular Diabetology|June 25, 2017
Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findingsRafael Y Brzezinski, Inbal Etz-Hadar, Ayelet Grupper, et al.
BMC Geriatrics|August 24, 2019
The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial)Assaf Buch, Roy Eldor, Ofer Kis, et al.
Diabetes Care|August 5, 2016
Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese SubjectsRoy Eldor, Giuseppe Daniele, Claudia Huerta, et al.
Diabetes/Metabolism Research and Reviews|May 24, 2020
Improving blood glucose level predictability using machine learningYonit Marcus, Roy Eldor, Mariana Yaron, et al.
Journal of Diabetes Science and Technology|January 30, 2024
Identifying Diabetes Related-Complications in a Real-World Free-Text Electronic Medical Records in Hebrew Using Natural Language Processing TechniquesMor Saban, Miri Lutski, Inbar Zucker, et al.
The Journal of Clinical Investigation|January 28, 2014
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose productionAurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Diabetes Care|August 27, 2016
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 DiabetesGiuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, et al.
Diabetes/Metabolism Research and Reviews|April 12, 2019
Exenatide modulates visual cortex responsesPaola Binda, Roy Eldor, Claudia Huerta, et al.
Cardiovascular Diabetology|June 25, 2017
Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findingsRafael Y Brzezinski, Inbal Etz-Hadar, Ayelet Grupper, et al.
BMC Geriatrics|August 24, 2019
The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial)Assaf Buch, Roy Eldor, Ofer Kis, et al.
Diabetes Care|August 5, 2016
Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese SubjectsRoy Eldor, Giuseppe Daniele, Claudia Huerta, et al.
Diabetes/Metabolism Research and Reviews|May 24, 2020
Improving blood glucose level predictability using machine learningYonit Marcus, Roy Eldor, Mariana Yaron, et al.
Journal of Diabetes Science and Technology|January 30, 2024
Identifying Diabetes Related-Complications in a Real-World Free-Text Electronic Medical Records in Hebrew Using Natural Language Processing TechniquesMor Saban, Miri Lutski, Inbar Zucker, et al.
The Journal of Clinical Investigation|January 28, 2014
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose productionAurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, et al.
Diabetes, Obesity & Metabolism|May 17, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trialPhilip D Home, Raymond L H Lam, Wendy L Carofano, et al.
Diabetes, Obesity & Metabolism|December 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trialRichard E Pratley, Roy Eldor, Annaswamy Raji, et al.
Pageof 7